Mount Sinai researchers succeed in programming blood forming stem cells
June 13, 2013 by admin2 · Leave a Comment
By transferring four genes into mouse fibroblast cells, researchers at the Icahn School of Medicine at Mount Sinai have produced cells that resemble hematopoietic stem cells, which produce millions of new blood cells in the human body every day. These findings provide a platform for future development of patient-specific stem/progenitor cells, and more differentiated blood products, for cell-replacement therapy.
Stem cells reach standard for use in drug development
June 11, 2013 by admin · Leave a Comment
Drug development for a range of conditions could be improved with stem cell technology that helps doctors predict the safety and the effectiveness of potential treatments.
Engineered stem cell advance gives hope for clinical trials for ALS
May 28, 2013 by admin2 · Leave a Comment
Transplantation of human stem cells in an experiment conducted at the University of Wisconsin-Madison improved survival and muscle function in rats used to model ALS, a nerve disease that destroys nerve control of muscles, causing death by respiratory failure.
Stem cell injections improve spinal injuries in rats
May 28, 2013 by admin · Leave a Comment
An international team led by researchers at the University of California, San Diego School of Medicine reports that a single injection of human neural stem cells produced neuronal regeneration and improvement of function and mobility in rats impaired by an acute spinal cord injury (SCI).
UCLA stem cell researchers move toward treatment for rare genetic nerve disease
May 15, 2013 by admin2 · Leave a Comment
Led by Dr. Peiyee Lee and Dr. Richard Gatti, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have used induced pluripotent stem (iPS) cells to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia telangiectasia (A-T).
Divide and define: Clues to understanding how stem cells produce different kinds of cells
May 6, 2013 by admin · Leave a Comment
The human body contains trillions of cells, all derived from a single cell, or zygote, made by the fusion of an egg and a sperm. That single cell contains all the genetic information needed to develop into a human, and passes identical copies of that information to each new cell as it divides into the many diverse types of cells that make up a complex organism like a human being.
Method makes it easier to separate useful stem cells from ‘problem’ ones for therapies
April 23, 2013 by admin · Leave a Comment
Pluripotent stem cells can turn, or differentiate, into any cell type in the body, such as nerve, muscle or bone, but inevitably some of these stem cells fail to differentiate and end up mixed in with their newly differentiated daughter cells.
Adhesive force differences enable separation of stem cells to advance regenerative therapies
April 7, 2013 by admin2 · Leave a Comment
A new separation process that depends on an easily-distinguished physical difference in adhesive forces among cells could help expand production of stem cells generated through cell reprogramming. By facilitating new research, the separation process could also lead to improvements in the reprogramming technique itself and help scientists model certain disease processes.
Researchers are first to use common virus to ‘fortify’ adult stem cells
April 1, 2013 by admin · Leave a Comment
Using the same strategy that a common virus employs to evade the human immune system, researchers at Wake Forest Baptist Medical Center’s Institute for Regenerative Medicine have modified adult stem cells to increase their survival – with the goal of giving the cells time to exert their natural healing abilities.
IUPUI stem cell research could expand clinical use of regenerative human cells
March 19, 2013 by admin · Leave a Comment
Research led by a biology professor in the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) has uncovered a method to produce retinal cells from regenerative human stem cells without the use of animal products, proteins or other foreign substances, which historically have limited the application of stem cells to treat disease and other human developmental disorders.



